{"nct_id":"NCT01064401","title":"Efficacy and Safety of BIIB019 (Daclizumab High Yield Process) Versus Interferon β 1a in Participants With Relapsing-Remitting Multiple Sclerosis","status":"COMPLETED","status_verified_date":"2016-05","start_date":"2010-05","start_date_type":null,"primary_completion_date":"2014-03","primary_completion_date_type":"ACTUAL","completion_date":"2014-07","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["BIIB"]}